logo_no_tag_2c.jpg
Sientra Announces $60 Million Convertible Notes Investment from Deerfield Management
March 11, 2020 16:01 ET | Sientra, Inc.
SANTA BARBARA, Calif., March 11, 2020 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a diversified medical aesthetics company, today announced that it has closed a...
logo_no_tag_2c.jpg
Sientra to Report 4Q19 Financial Results on March 11, 2020
February 26, 2020 16:05 ET | Sientra, Inc.
SANTA BARBARA, Calif., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Sientra, Inc. (Nasdaq: SIEN), a medical aesthetics company, announced today that it will release 4Q19 financial results after the close of...
logo_no_tag_2c.jpg
Sientra to Present at the 9th Annual SVB Leerink Global Healthcare Conference
February 20, 2020 17:52 ET | Sientra, Inc.
SANTA BARBARA, Calif., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company, announced today that members of management are scheduled to present at the 9th...
logo_no_tag_2c.jpg
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
February 19, 2020 17:00 ET | Sientra, Inc.
SANTA BARBARA, Calif., Feb. 19, 2020 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today announced that on February 13, 2020, the...
logo_no_tag_2c.jpg
Sientra Announces Preliminary Unaudited 4Q19 Net Sales and Appointment of Caroline Van Hove to Board of Directors
January 13, 2020 07:00 ET | Sientra, Inc.
Anticipates total fourth quarter net sales of $23.2 million, growth of 22% year over year Aesthetics industry executive Caroline Van Hove joins Sientra’s Board of Directors SANTA BARBARA, Calif.,...
logo_no_tag_2c.jpg
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
December 16, 2019 16:05 ET | Sientra, Inc.
SANTA BARBARA, Calif., Dec. 16, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company, today announced that on December 3, 2019, the Compensation Committee of the...
logo_no_tag_2c.jpg
Sientra Reports Third Quarter 2019 Financial Results
November 07, 2019 16:07 ET | Sientra, Inc.
Highlights: Record total net sales of $22.4 million in 3Q19, growth of 33% year over yearBreast Products net sales of $12.6 million in 3Q19, growth of 47% year over yearRecord miraDry net sales of...
logo_no_tag_2c.jpg
Sientra Announces Acquisition of the Independently Operated OPUS® Breast Implant Manufacturing Operation from Lubrizol Life Science
November 07, 2019 16:01 ET | Sientra, Inc.
Vertical integration critical next step in advancing Sientra’s strategic objectives Insourcing of breast implant supply chain provides numerous operational and financial advantages SANTA...
logo_no_tag_2c.jpg
Sientra to Participate in Upcoming Investor Conferences
October 31, 2019 16:30 ET | Sientra, Inc.
SANTA BARBARA, Calif., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (Nasdaq: SIEN), a medical aesthetics company, announced today that its management team will participate in the following...
logo_no_tag_2c.jpg
Sientra to Report Third Quarter 2019 Financial Results on November 7, 2019
October 17, 2019 16:05 ET | Sientra, Inc.
SANTA BARBARA, Calif., Oct. 17, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (Nasdaq: SIEN), a medical aesthetics company, announced today that it will release financial results for the third quarter 2019...